BASEL LIFE 2019

9–12 September 2019

Congress Center Basel
Switzerland

Aging, Drug Discovery & Artificial Intelligence

Date

Tuesday & Thursday, 10-12 September 2019

Chairs

Alex Zhavoronkov (InSilico Medicine, Baltimore, United States)
Morten Scheibye-Knudsen (Danish Center for Aging Research/National Institute on Aging, Copenhagen, Denmark)

Abstract

In this symposium, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the forum will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. This event intends to bridge academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. A panel of thought-leaders will give us their cutting edge reports on the latest progress in our quest to extend the healthy lifespan of everyone on the planet. Please join us in this merger of driven scientists and global visionaries in an event that may shape the field in years to come.

Tuesday, 10 September 2019

10.00 – 16.30

10.00
Title to be announced
Brian Kennedy (NUS, Singapore, SG)


10.20
Mitochondrial Metabolic Checkpoint, Stem Cell Aging and Rejuvenation
Danica Chen (University of California, Berkeley, USA)

10.40
"Translational geroscience: A new paradigm for 21st Century Medicine"
Ph. D. Matt Kaeberlein (University of Washington, Seattle, USA)

11.00
Break

11.30
New discoveries about ageing in C. elegans
Professor, Ph., D. David Gems (UCL, London, UK)

11.50
Rejuvenation biotechnology: why age may soon cease to mean aging
Ph. D.  
Aubrey de Grey (AgeX / SENS Research Foundation, London, UK)

12.10
Title to be announced
Alex Aliper (Insilico Medicine, Baltimore, USA)


12.45
Lunch Break & Industry Symposia

14.00
Drivers of neurotoxicity in prion diseases
Adriano Aguzzi (University of Zurich, Zurich, CH)

14.20
Leucine signals to mTORC1 via its metabolite acetyl-coenzyme APhD, FMedSci
Professor David Rubinsztein (Cambridge Institute for Medical Research, Cambridge, UK)

14.40
Convergent mechanisms of longevity
Adam Antebi (Max Planck Institute for Biology of Ageing, Cologne, DE)

15.00
Break

15.30
Impact of food perception on proteostasis & aging

Thorsten Hoppe (University of Cologne, Cologne, DE)

15.50
The art of decision-making by stem cells in the aging brain
Ana Martin- Villalba (DKFZ, Heidelberg, DE)

16.10
Power and benefit of selective phosphatase inhibition for neurodegenerative diseases
Ph.D., FMedSci. Anne Bertolotti (MRC Laboratory of Molecular Biology, Cambridge, UK)

 

 

Room Sydney

Wednesday, 11 September 2019

10.00-15.30

10.00
Title to be announced
Andrea Ablasser (EPFL, Lausanne, CH)

10.20
Title to be announced
Maria Blasco (CNIO, Madrid, ES)

10.40
Protecting the Aging Genome
M.D., Ph. D. Morten Scheibye-Knudsen (Center for Healthy Aging, Copenhagen, DK)

11.00
Break

11.30 
Title to be announced
Rafael de Cabo (NIA-NIH, Baltimore, USA)

11.50
From Longevity Signatures to Longevity Interventions
Vadim Gladyshev (Harvard Medical School, Boston, USA)


12.10
How to obtain an indication that targets health span
M.D., Ph. D. Nir Barzilai (Albert Einstein College, New York, USA)

12.45 
Lunch Break & Industry Symposia


14.00
Making aging biology part of drug development
Martin Borch Jensen (Gordian Biotechnology, San Francisco, USA)

14.20
Short talks from abstracts

14.40
Panel discussion

15.00
Break

15.30
EMBO Plenary session 5: Regenerative medicine (on Aging)


Room Sydney

15.30-17.40

EMBO Plenary session 5: Regenerative medicine (on Aging)

Room Montreal

Thursday, 12 September 2019

09.00-10.15

Plenary session 6 (Joint with [BC]2) Computational biology, artificial intelligence, machine learning in precision medicine

Room Montreal

10.45-15.30

10.45
Title to be announced
Ph. D. Alex Zhavoronkov (Insilico Medicine, Rockville, USA)

11.05
Title to be announced
Martin-Immanuel Bittner (Arctoris, Oxford, UK)

11.25
Title to be announced

Tyler Golato (Wildwood, US) 

11.45
Break

12.00
Title to be announced
Speaker to be announced

12.20
Ketogenic diet to delay brain aging in Cockayne syndrome
Michael A. Petr (University of Copenhagen, Copenhagen, DK)

12.40
Title to be announced
Speaker to be announced

13.00
Lunch Break & Industry Symposia

14.30
Title to be announced
Speaker to be announced

14.50
Title to be announced
Speaker to be announced

15.00
Longevity VC panel
Speaker to be announced

 

 

Room Sydney

Main sponsor(s)

Supporter(s)